Employer record no. 14045
Novartis Gene Therapies, Inc.
US DOL LCA disclosure data, FY2021 to FY2026
Total LCA filings
24
Certified
24
Denied
0
FY2025 filings
4
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#1,197 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2021 | 6 | 6 | 0 | $99,431 | $99,431 |
| FY2022 | 6 | 6 | 0 | $112,029 | $112,029 |
| FY2023 | 6 | 6 | 0 | $92,449 | $91,610 |
| FY2025 | 4 | 4 | 0 | $100,407 | $98,316 |
| FY2026 * | 2 | 2 | 0 | $86,955 | $80,319 |
What they file for
- manufacturing quality assurance specialist$85,3223
- senior project manager, manufacturing science and technology$102,2422
- specialist, quality control$96,6472
- associate director, regions global regulatory affairs$169,5421
- bio process engineer ii$89,0451
- business systems analyst$79,7471
- business systems analyst 2$96,0541
- director, global real-world evidence$141,3781
Where
- durham, nc15
- libertyville, il4
- bannockburn, il1
- deerfield, il1
- north royalton, oh1
- ridgewood, nj1
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Novartis Gene Therapies, Inc. and any other employer they watch.
Certification rate 100.0%How these numbers are computed